Paul R. Vigano Sells 750,000 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder Paul R. Vigano sold 750,000 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the completion of the sale, the insider now directly owns 28,890,756 shares in the company, valued at approximately $150,231,931.20. This represents a 2.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Down 3.3%

AVAH traded down $0.17 during trading on Friday, hitting $4.91. The company's stock had a trading volume of 437,916 shares, compared to its average volume of 327,223. The stock has a market capitalization of $957.91 million, a price-to-earnings ratio of -14.44 and a beta of 2.03. Aveanna Healthcare Holdings Inc. has a 12 month low of $2.32 and a 12 month high of $6.19. The firm's 50 day moving average price is $5.09 and its two-hundred day moving average price is $4.91.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its position in shares of Aveanna Healthcare by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company's stock worth $246,000 after acquiring an additional 2,649 shares during the last quarter. Rhumbline Advisers raised its position in shares of Aveanna Healthcare by 4.0% during the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after acquiring an additional 2,918 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Aveanna Healthcare by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock worth $2,133,000 after acquiring an additional 4,047 shares during the last quarter. MetLife Investment Management LLC raised its position in shares of Aveanna Healthcare by 16.2% during the first quarter. MetLife Investment Management LLC now owns 31,251 shares of the company's stock worth $169,000 after acquiring an additional 4,349 shares during the last quarter. Finally, AQR Capital Management LLC raised its position in shares of Aveanna Healthcare by 21.2% during the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company's stock worth $142,000 after acquiring an additional 4,602 shares during the last quarter. Institutional investors own 87.96% of the company's stock.

Analysts Set New Price Targets

AVAH has been the subject of several research analyst reports. UBS Group lifted their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a research report on Friday, April 11th.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.